Ependymoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials
• Forums

Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults With Recurrent or Residual Posterior Fossa Ependymoma
Condition:   Fossa Ependymoma Intervention:   Drug: 5-Azacytidine and trastuzumab infusion Sponsor:   The University of Texas Health Science Center, Houston Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2021 Category: Research Source Type: clinical trials

Combination Intraventricular Chemotherapy Pilot Study: 5-Azacytidine (5-AZA) and Trastuzumab Infusions Into the Fourth Ventricle or Resection Cavity in Children and Adults With Recurrent or Residual Posterior Fossa Ependymoma
Condition:   Fossa Ependymoma Intervention:   Drug: 5-Azacytidine and trastuzumab infusion Sponsor:   The University of Texas Health Science Center, Houston Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2021 Category: Research Source Type: clinical trials

HER2-specific CAR T Cells for Children With Ependymoma
Condition:   Ependymoma Intervention:   Biological: HER-2 Specific CAR T Cell Sponsors:   Pediatric Brain Tumor Consortium;   Texas Children's Cancer Center;   Baylor College of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 26, 2021 Category: Research Source Type: clinical trials